Evidence map›Paper›PMID 39368335›Full record

Trial reportJournal of geriatric oncology2024

The effect of YOCAS©® yoga on cancer-related fatigue and quality of life in older (60+) vs. younger (≤ 59) cancer survivors: Secondary analysis of a nationwide, multicenter, phase 3 randomized controlled trial.

Evelyn Arana-Chicas, Po-Ju Lin, Umang Gada, Hongying Sun, Alisha Chakrabarti, Lindsey J Mattick, Katherine Rieth, Christopher H Chay, Janet Ruzich, Benjamin T Esparaz and 5 more

Registry-linked trialAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of geriatric oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00397930 (Yoga for Persistent Sleep Disturbance in Cancer Survivors), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00397930 phase2completednot on this map

Yoga for Persistent Sleep Disturbance in Cancer Survivors

TypeinterventionalSponsorGary MorrowRan2006 to 2013Enrolled410ConditionsFatigue, Cancer, Sleep DisordersArmsStandard Care Control Condition, Yoga Intervention (YOCAS)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Efficacy of different non-pharmacological therapies on cancer-related fatigue in breast cancer patients: a network meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Evelyn Arana-ChicasRutgers Cancer Institute of NJ, Rutgers University, New Brunswick, NJ 08901, United States of America. Electronic address: earana@cinj.rutgers.edu.
Po-Ju LinJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Umang GadaJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Hongying SunJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Alisha ChakrabartiJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Lindsey J MattickJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Katherine RiethJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Christopher H ChaySoutheast Clinical Oncology Research Consortium (SCOR), Winston-Salem, NC, United States of America.
Janet RuzichPacific Cancer Research Consortium (PCRC), Oregon City, OR, United States of America.
Benjamin T EsparazHeartland Cancer Research NCORP (HEARTLAND), Decatur, IL, United States of America.
Ana P CupertinoJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Brian J AltmanJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Biomedical Genetics, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Paula M VertinoJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Biomedical Genetics, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Supriya G MohileJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Geriatric Oncology Research Group, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
Karen M MustianJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral MechanismsR01CA181064 · NCI · UNIVERSITY OF ROCHESTER · PI MUSTIAN, KAREN M. · 2014 to 2019
$3.1M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
NCI NIH HHS R01 CA181064NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589
6 · The paper itself

Abstract

introductionOlder cancer survivors consistently express the need for interventions to reduce cancer-related fatigue (CRF) and maintain quality of life (QOL). Yoga is a promising treatment to address CRF and QOL. However, research comparing the efficacy of yoga for improving fatigue and QOL in older survivors (60+) vs. younger adult survivors (≤59)is limited. Our objective was to examine the effects of yoga on CRF and QOL in older survivors vs. younger survivors. MATERIALS AND

methodsWe conducted a secondary analysis of a nationwide, multicenter, phase 3 randomized controlled trial. For this study, participants who provided evaluable pre- and post-intervention data on the Functional Assessment for Chronic Illness Therapy-Fatigue (FACIT-F) and the Functional Assessment for Cancer Therapy-General (FACT-G) were eligible. The yoga intervention comprises gentle Hatha and Restorative Yoga and includes breathing exercises, physical alignment postures, and mindfulness.

resultsOf the 177 participants included in the study, 30.1 % were aged 60+ and 69.9 % were aged ≤59. More younger participants had breast cancer (82.0 % vs. 59.2 %. p = 0.009), surgery (98.9 % vs. 77.8 %, p < 0.001), and chemotherapy (80.5 % vs. 55.6 %, p = 0.001). There were no differences in the cancer stage (66.1 % stage I or II). There were statistically significant and clinically meaningful within-group improvements from baseline to post-intervention in CRF for participants aged ≤59 and participants aged 60+ (4.0 ± 0.7, p < 0.001 vs. 3.1 ± 1.0, p = 0.003). Both age groups also demonstrated improvements in QOL (3.2 ± 0.8, p < 0.001 vs. 2.1 ± 1.2, p = 0.078), physical (1.6 ± 0.3, p < 0.001 vs. 0.8 ± 0.5, p = 0.084), functional (0.7 ± 0.3, p = 0.048 vs. 1.0 ± 0.5, p = 0.037), and emotional well-being. There were no significant between-group differences between the age groups. Most younger and older participants reported that yoga helped improve their sleep quality (92.8 % vs 88.5 %) and they would recommend it to other survivors (98.2 % vs 90.4 %). DISCUSSION: Older cancer survivors who undergo gentle Hatha and restorative yoga performed two to three times per week for four weeks at a low to moderate level of intensity have similar improvements in CRF and QOL compared to participants aged ≤59. For older survivors experiencing these toxicities, it is reasonable for clinicians to prescribe yoga. CLINICALTRIALS: govidentifier: NCT00397930.

Indexed as

Cancer SurvivorsFatigueNeoplasmsQuality of LifeYogaAdultAgedAge FactorsFemaleHumansMaleMiddle AgedCancer survivorsFatigueGeriatric oncologyIntegrative oncologyPhysical activityQuality of lifeSupportive careSymptom managementYoga

Identifiers

PMID39368335
PMCPMC11822854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.